| Particulars |
|
|
|
|
Company Name
| Novartis India Ltd
|
Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
12.35 |
B.V. (₹) |
331.20 |
| Sales(₹ Cr.) |
376.96 |
NP (₹ Cr.) |
93.20 |
| NP Var% |
-8.00 |
Div% |
500.00 |
| CPS(₹) |
38.50 |
EPS (₹) |
37.70 |
| Traded Value(₹ Lakhs) |
27.74 |
52 Week High |
2,588.00 |
| 52 Week Low |
750.00 |
Price BSE |
2,013.00 |
| Price NSE |
2,013.00 |
Market Capital (₹ Cr.) |
4,971.12 |
| P/C Ratio |
52.20 |
P/E Ratio |
53.30 |
| Price Vs.BV |
6.08 |
|
| Latest Quarter |
| Year End |
202606 |
Sales (₹ Cr.) |
103.81 |
| NP(₹ Cr.) |
32.21 |
NP Var % |
17.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
345.11 |
| OPM |
21.13 |
NP |
87.40 |
| NP Var% |
-4.87 |
EPS |
39.60 |
| PE |
50.84 |
|
|